Based on recent studies that have demonstrated circulating EPCs using flow cytometry8, 24, 25, the numbers of CD34+ VEGFR2+ double-positive cells were first determined in the peripheral blood of breast disease patients and healthy controls (Fig. 1A). This evidence concerns the gene CD34 and breast disorder.